| abstract |
A method is provided for both prophylactic and therapeutic treatment of conditions associated with amyloid β (Aβ) peptide activity. A molecule comprising a Fab fragment that specifically binds to human Aβ peptide between amino acid positions 13 to 28, wherein the Fab fragment comprises a specific sequence, a light chain variable region and a heavy chain variable A molecule comprising a region, wherein a polyethylene glycol molecule is covalently linked to the CDR of the heavy chain variable region of the Fab fragment. [Selection figure] None |